- Aberrant Promoter Methylation of Death-Associated Protein Kinase in Serum DNA from Lung Cancer Patients
-
Lee JH, Lee JW, Jung KS, Kim KU, Lee TK, Lee KW, Na MA, Jeon DS, Choi YM, Kim YS, Lee MK, Park SK
- KMID: 2318433
- Tuberc Respir Dis.
- 2003 Oct;55(4):378-387.
BACKGROUND: Promoter methylation of tumor suppressor genes is one of the key epigenetic changes in many human cancers. The aim of this study was to evaluate the promoter methylation status... -
- CITED
-
- Close
- SHARE
-
- Close
- Aberrant Methylation of p16 Tumor Suppressor Gene and Death-Associated Protein Kinase in Non-Small Cell Lung Carcinoma
-
Kim YS, Lee MK, Jung KS, Kim KU, Kim YD, Lee HR, Lee CH, Seok JW, Kim YK, Jun ES, Choi YM, Rha SH, Park SK
- KMID: 2318343
- Tuberc Respir Dis.
- 2001 Aug;51(2):108-121.
- doi: 10.4046/trd.2001.51.2.108
BACKGROUND: The p16INK4a (p16) tumor suppressor gene is frequently inactivated in human non-small cell lung cancers (NSCLCs), predominantly through homozygous deletion or in association with aberrant promotor hypermethylation. Death-associated protein... -
- CITED
-
- Close
- SHARE
-
- Close
- Transcriptome Analysis Identifies an Attenuated Local Immune Response in Invasive Nonfunctioning Pituitary Adenomas
-
Kim YH, Kim JH
- KMID: 2458634
- Endocrinol Metab.
- 2019 Sep;34(3):314-322.
- doi: 10.3803/EnM.2019.34.3.314
BACKGROUND: Invasive nonfunctioning pituitary adenomas (NFPAs) remain challenging due to their high complication rate and poor prognosis. We aimed to identify the distinctive molecular signatures of invasive NFPAs, compared with... -
- CITED
-
- Close
- SHARE
-
- Close
